LAURUS LABS
Back to Income Statement
|
LAURUS LABS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹358 Cr | ₹158 Cr | ₹785 Cr | ₹828 Cr | ₹984 Cr |
What is the latest Consolidated Net Profit of LAURUS LABS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹358 Cr |
| Mar2025 | ₹158 Cr |
| Mar2024 | ₹785 Cr |
| Mar2023 | ₹828 Cr |
| Mar2022 | ₹984 Cr |
How is Consolidated Net Profit of LAURUS LABS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹358 Cr | 127.25 | |
| Mar2025 | ₹158 Cr | -79.90 | |
| Mar2024 | ₹785 Cr | -5.20 | |
| Mar2023 | ₹828 Cr | -15.87 | |
| Mar2022 | ₹984 Cr | - | |
Compare Consolidated Net Profit of peers of LAURUS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LAURUS LABS | ₹108,708.4 Cr | 0.3% | 4.8% | 121.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,478.0 Cr | -0.2% | -3.2% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,031.0 Cr | 2% | 5.3% | 57.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,216.0 Cr | -2.4% | -3.1% | 36.4% | Stock Analytics | |
| CIPLA | ₹112,205.0 Cr | 0.6% | -2.2% | -9.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,040.0 Cr | 0.9% | 4% | -7.6% | Stock Analytics | |
LAURUS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LAURUS LABS | 0.3% |
4.8% |
121.3% |
| SENSEX | -2.8% |
-6.1% |
-11.9% |
You may also like the below Video Courses